Stocks
Fortrea Holdings Inc.FTRE
NASDAQHealthcareBiotechnology$8.93-1.22%
Price as of · delayed, not real-time
A global contract research organization (CRO) providing comprehensive Phase I-IV clinical trial management, regulatory, and patient access solutions to biopharmaceutical and medical device companies. The company is closely monitored by investors due to its role in accelerating drug development and its exposure to the growing demand for outsourced clinical research services.
Market Cap: $835.0M52W Range: $3.97 – $18.67
Congressional Interest in Fortrea Holdings Inc. (FTRE)
2 members of Congress have disclosed 2 trades in Fortrea Holdings Inc. (FTRE), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
1
Sells
1
Who in Congress Is Trading FTRE?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-06-23 | JAMES FRENCH HILL | sell | $1K – $15K |
| 2018-11-05 | JAMES B. RENACCI | buy | $1K – $15K |